New York Codes, Rules and Regulations › Title 10 - DEPARTMENT OF HEALTH › Chapter II - Administrative Rules and Regulations › Subchapter G - Aids Testing, Communicable Diseases and Poisoning › Part 67 - Lead Poisoning Prevention And Control › Subpart 67-1 - Screening And Follow-up › Section 67-1.2 - Lead screening and follow-up of children by health care providers

Current through Register Vol. 46, No. 28, July 10, 2024
(a) Lead screening
					 and follow-up of children by primary health care providers.
(1) At each routine well-child visit, or at
					 least annually if a child has not had routine well-child visits, primary health
					 care providers shall assess each child who is at least six months of age but
					 under six years of age, for high dose lead exposure using a risk assessment
					 tool based on currently accepted public health guidelines. Each child found to
					 be at risk for high dose lead exposure shall be screened or referred for lead
					 screening.
(2) Primary health care
					 providers shall provide the parent or guardian of each child under six years of
					 age anticipatory guidance on lead poisoning prevention as part of routine
					 care.
(3) Primary health care
					 providers shall screen or refer each child for blood lead screening, at or
					 around one and two years of age, preferably as part of routine well child
					 care.
(4) The Commissioner of
					 Health may provide recommended alternative schedules for other high risk groups
					 as deemed necessary.
(5) Results of
					 blood lead analysis performed in a health care practitioner's office pursuant
					 to Public Health Law, section
					 579(1) that is certified by
					 the Centers for Medicare and Medicaid Services under regulations implementing
					 the Federal Clinical Laboratory Improvement Amendments of 1988 (CLIA) must be
					 reported to the Commissioner of Health and to the local health officer in whose
					 jurisdiction the subject of the test resides. Such results shall be reported
					 within 14 business days of the date of analysis and on such forms as prescribed
					 by the Commissioner of Health. Such reports must include the subject's name,
					 date of birth, race, gender, address, county of residence, type of sample
					 (venous or fingerstick) and blood lead level; the health care practitioner
					 ordering the test, facility identifiers, the date of sample collection, and the
					 date of analysis.
(6) Each primary
					 health care provider who screens a child for elevated blood lead levels shall
					 explain the blood lead test results and provide documentation of lead screening
					 to the parent or guardian of the child or other person authorized to consent
					 for the medical care of the child.
(7) Primary health care providers shall
					 provide or make reasonable efforts ensure the provision of follow-up testing
					 for each child with an elevated blood lead level in accordance with currently
					 accepted medical standards and public health guidelines.
(8) Primary health care providers shall
					 provide or make reasonable efforts to ensure the provision of risk reduction
					 education and nutritional counseling for each child with an elevated blood lead
					 level equal to or greater than 5 micrograms per deciliter of whole
					 blood.
(9) Primary health care
					 providers shall confirm blood lead le vels equal to or greater than 5
					 micrograms per deciliter of whole blood obtained on a capillary specimen from a
					 child using a venous blood sample
(10) For each child who has a confirmed blood
					 lead level equal to or greater than 5 micrograms per deciliter of whole blood,
					 primary health care providers shall provide or make reasonable efforts to
					 ensure the pro- vision of a complete diagnostic evaluation; medical treatment,
					 if necessary; and referral to the appropriate local or State health unit for
					 environmental management. A complete diagnostic evaluation shall include at a
					 minimum: a detailed lead exposure assessment, a nutritional assessment
					 including iron status, and a developmental screening.
(11) Primary health care providers shall
					 communicate and coordinate as appropriate with local health units to ensure
					 that each child with an elevated blood lead level receives appropriate
					 follow-up, as prescribed in paragraphs (6) through (10) of this
					 subdivision.